Discover
PHVS
Pharvaris N.V.
33.95
2 x 24.85
2 x 42.71
bid
ask
-
0.63
1.82%
2 @ 04:00 PM
33.95 +0.00 (0.00%)
| Ytd | 22.34% | |
| 1y | 96.81% |
33.22
day range
34.58
17.05
52 week range
35.91
| Open | 34.58 | Prev Close | 34.58 | Low | 33.22 | High | 34.58 | Mkt Cap | 2.37B |
| Vol | 374.40K | Avg Vol | 352.43K | EPS | -3.10 | P/E | N/A | Forward P/E | -12.83 |
| Beta | -2.33 | Short Ratio | 3.30 | Inst. Own | 85.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 30.84 | 200-d Avg | 26.87 | 1yr Est | 46.09 |
| Income Statement | |||
| Operating Expenses | 44.27M | ||
| Research and Development Expense | 30.16M | ||
| Selling, General and Administrative Expense | 14.11M | ||
| Operating Income | -44.27M | ||
| Interest Expense | -5.34M | ||
| Income Tax Expense | 273.11K | ||
| Net Income | -39.20M | ||
| Net Income Common Stock | -39.20M | ||
| Net Income Common Stock (USD) | -45.06M | ||
| Consolidated Income | -39.20M | ||
| Earnings per Basic Share | -0.60 | ||
| Earnings per Basic Share (USD) | -0.69 | ||
| Earnings per Diluted Share | -0.60 | ||
| Earning Before Interest & Taxes (EBIT) | -44.27M | ||
| Earning Before Interest & Taxes (USD) | -50.89M | ||
| Weighted Average Shares | 64.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 246.96M | ||
| Cash and Equivalents (USD) | 283.86M | ||
| Trade and Non-Trade Receivables | 969.63K | ||
| Current Assets | 253.68M | ||
| Property, Plant & Equipment Net | 1.36M | ||
| Total Assets | 259.79M | ||
| Debt Current | 206.31K | ||
| Total Debt | 738.89K | ||
| Debt Non-Current | 532.58K | ||
| Total Liabilities | 23.46M | ||
| Accumulated Retained Earnings (Deficit) | -619.54M | ||
| Accumulated Other Comprehensive Income | -169.32K | ||
| Shareholders Equity | 236.33M | ||
| Shareholders Equity (USD) | 271.65M | ||
| Assets Non-Current | 6.11M | ||
| Total Debt (USD) | 849.30K | ||
| Trade and Non-Trade Payables | 2.71M | ||
| Tax Assets | 4.75M | ||
| Tax Liabilities | 960.81K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 104.73K | ||
| Net Cash Flow from Financing | -61.51K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -48.88M | ||
| Capital Expenditure | -52.10K | ||
| Issuance (Repayment) of Debt Securities | -61.51K | ||
| Net Cash Flow from Investing | -52.10K | ||
| Net Cash Flow from Operations | -48.77M | ||
| Effect of Exchange Rate Changes on Cash | 4.16M | ||
| Share Based Compensation | 4.90M | ||